# An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia

> **NCT01921868** · NA · UNKNOWN · sponsor: **University of South Florida** · enrollment: 20 (estimated)

## Conditions studied

- Friedreich's Ataxia

## Interventions

- **DRUG:** Acetyl-L-Carnitine

## Key facts

- **NCT ID:** NCT01921868
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2016-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01921868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01921868, "An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01921868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*